Jay Moyes, Director at Puma Biotechnology, holds 43.32K shares in Puma Biotechnology (Ticker: PBYI), holds 0.00 shares in Achieve Life Sciences (Ticker: ACHV), holds 35.63K shares in Sera Prognostics (Ticker: SERA).
Jay Moyes latest transaction was an Uninformative Buy of ―.
What was Jay Moyes's most profitable transaction?
Jay Moyes’s most profitable transaction was an Informative Sell of PBYI stock on June 11, 2021. The return on the trade was 77.10%.
What is Jay Moyes's role in Puma Biotechnology?
Jay Moyes's role in Puma Biotechnology is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.